The first half of 2026 has tested investors with geopolitical uncertainty, inflationary pressure and a more selective financing environment. Yet healthcare has continued to demonstrate the qualities that have long made it one of Europe's most resilient investment sectors.
Keeping pace with every report, briefing and market update is not easy, so HBI has selected five healthcare investment reports from Q2 2026 that are worth your time.
Together, they provide a useful view of where capital is concentrating, how dealmaking is evolving and the trends investors should be watching during the second half of 2026.
#1.
Healthcare M&A trends: European Private Equity Outlook for 2026
Publication: Kearney
Healthcare continues to stand out as one of Europe's strongest destinations for private equity, but capital is becoming increasingly selective. Kearney explains why investors are rotating away from more volatile life sciences segments and concentrating on healthcare services, diagnostics, imaging and other scalable platform opportunities. It is a valuable overview of where competition for quality assets is likely to intensify.
#2.
Healthcare and pharma services M&A review: Spring 2026
Publication: Grant Thornton UK
UK healthcare deal activity accelerated sharply during the first quarter, supported by resilient investor demand and a renewed focus on specialist providers. Beyond the headline figures, this review highlights two themes likely to shape transactions over the coming months: continued consolidation across fragmented provider markets and growing regulatory scrutiny of larger acquisitions. For anyone tracking UK healthcare services, it provides useful context behind the numbers.
#3.
Proof, Precision, and Power: Europe's Digital Health Finding Market in Q1 2026
Publication: Galen Growth
European digital health is entering a more disciplined phase. Funding volumes have moderated, but larger rounds are increasingly concentrated behind businesses with proven commercial traction and embedded clinical value. The report also highlights a significant shift in hospital adoption, with healthcare providers becoming more active partners for digital health companies. It is an important read for investors assessing where digital health is creating sustainable value rather than speculative growth.
#4.
The European Commission's Draft Merger Guidelines
Publication: Goodwin
This quarter's proposed changes to EU merger guidance could reshape transaction planning across healthcare and life sciences. The Commission's increasing focus on innovation, ecosystems and future competition means buyers may face a more complex review process even where traditional market share concerns appear limited. The briefing offers a practical explanation of how regulatory expectations are evolving before the new framework comes into force.
🌟Premium Feature: Available free until Friday 24th July🌟
#5.
HBI 2026 Healthcare Property Report
Publication: Healthcare Business International
Healthcare real estate is emerging as one of the most compelling long-term investment themes in European healthcare, but the market remains far from straightforward. HBI's 2026 Healthcare Property Report examines how investors, operators and developers are responding to rising construction costs, ageing infrastructure and growing demand for care capacity. Drawing on interviews with leading healthcare property investors, operators and advisers from across Europe, the report explores where capital is flowing, how investment strategies are evolving and the innovative development models beginning to reshape the sector. For anyone evaluating opportunities across healthcare real estate, it offers practical insight into one of the market's fastest-evolving asset classes.
Download the 2026 Healthcare Property Report - Available until July 24.
Stay ahead of the market.
These five articles capture many of the themes shaping healthcare investment in 2026, from shifting private equity strategies and digital health funding to regulatory change and provider consolidation. They also demonstrate how quickly the market evolves.
HBI Intelligence helps healthcare investors, advisors and providers stay ahead of market developments with exclusive reporting, in-depth market intelligence and premium research covering healthcare markets across Europe and beyond. Members gain access to expert analysis, comprehensive market overviews, special reports and an extensive database of healthcare companies, investors and transactions, helping them understand not just what is happening, but why it matters.
